Literature DB >> 34257278

Induced TRIM21 ISGylation by IFN-β enhances p62 ubiquitination to prevent its autophagosome targeting.

Jie Jin1, Xianbin Meng1, Yi Huo2, Haiteng Deng3.   

Abstract

The tripartite motif-containing protein 21 (TRIM21) plays important roles in autophagy and innate immunity. Here, we found that HECT and RLD domain containing E3 ubiquitin protein ligase 5 (HERC5), as an interferon-stimulated gene 15 (ISG15) E3 ligase, catalyzes the ISGylation of TRIM21 at the Lys260 and Lys279 residues. Moreover, IFN-β also induces TRIM21 ISGylation at multiple lysine residues, thereby enhancing its E3 ligase activity for K63-linkage-specific ubiquitination and resulting in increased levels of TRIM21 and p62 K63-linked ubiquitination. The K63-linked ubiquitination of p62 at Lys7 prevents its self-oligomerization and targeting to the autophagosome. Taken together, our study suggests that the ISGylation of TRIM21 plays a vital role in regulating self-oligomerization and localization of p62 in the autophagy induced by IFN-β.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34257278     DOI: 10.1038/s41419-021-03989-x

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  41 in total

1.  ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP.

Authors:  Fumihiko Okumura; Weiguo Zou; Dong-Er Zhang
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

2.  HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.

Authors:  Joyce Jing Yi Wong; Yuh Fen Pung; Newman Siu-Kwan Sze; Keh-Chuang Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

Review 3.  ISG15 in cancer: Beyond ubiquitin-like protein.

Authors:  Hye Gyeong Han; Hye Won Moon; Young Joo Jeon
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

4.  Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein.

Authors:  W Yuan; R M Krug
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

5.  Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin.

Authors:  A L Haas; P Ahrens; P M Bright; H Ankel
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

6.  UBP43 (USP18) specifically removes ISG15 from conjugated proteins.

Authors:  Michael P Malakhov; Oxana A Malakhova; Keun Il Kim; Kenneth J Ritchie; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

7.  The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.

Authors:  Weiguo Zou; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2005-12-13       Impact factor: 5.157

8.  Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.

Authors:  Anahita Dastur; Sylvie Beaudenon; Melissa Kelley; Robert M Krug; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

9.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

Review 10.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

View more
  2 in total

1.  TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer.

Authors:  Jieyun Sun; Xintian Chen; Xueying Ji; Sen Meng; Wenwen Wang; Pengfei Wang; Jin Bai; Zhongwei Li; Youguo Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 2.  The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment.

Authors:  Xintian Chen; Menghan Cao; Pengfei Wang; Sufang Chu; Minle Li; Pingfu Hou; Junnian Zheng; Zhongwei Li; Jin Bai
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.